Sotalol

Sotalol is a non-selective beta-adrenergic blocking agent with additional Class III antiarrhythmic properties used as an active pharmaceutical ingredient. Mediocon Inc supplies high-purity Sotalol API conforming to BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.

Sotalol prolongs cardiac action potential duration and the effective refractory period through potassium channel blockade, in addition to beta-adrenoceptor blocking activity. It is used for the management of life-threatening ventricular arrhythmias and atrial fibrillation.

Key Features

• High-purity pharmaceutical grade API
• BP / EP / USP / INH / FCC / NF compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Ventricular tachycardia and fibrillation
• Atrial fibrillation and flutter
• Supraventricular tachycardia
• Postoperative arrhythmia management

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings